Skip to main content
Top
Published in: Diabetologia 3/2014

01-03-2014 | Article

Circulating levels of perfluoroalkyl substances and prevalent diabetes in the elderly

Authors: Lars Lind, Björn Zethelius, Samira Salihovic, Bert van Bavel, P. Monica Lind

Published in: Diabetologia | Issue 3/2014

Login to get access

Abstract

Aims/hypothesis

Several environmental contaminants, such as polychlorinated biphenyls, dioxins, bisphenol A and phthalates, have been linked to diabetes. We therefore investigated whether other kinds of contaminants, perfluoroalkyl substances (PFAS), also called perfluorinated compounds (PFCs), are also associated with diabetes.

Methods

The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study investigated 1,016 men and women aged 70 years. Seven PFAS were detected in almost all participant sera by ultra-high performance liquid chromatograph/tandem mass spectrometry. Diabetes was defined as use of hypoglycaemic agents or fasting glucose >7.0 mmol/l.

Results

114 people had diabetes. In the linear analysis, no significant relationships were seen between the seven PFAS and prevalent diabetes. However, inclusion of the quadratic terms of the PFAS revealed a significant non-linear relationship between perfluorononanoic acid (PFNA) and diabetes, even after adjusting for multiple confounders (OR 1.96, 95% CI 1.19, 3.22, p = 0.008 for the linear term and OR 1.25, 95% CI 1.08, 1.44, p = 0.002 for the quadratic term). Perfluorooctanoic acid (PFOA) also showed such a relationship (p = 0.01). PFOA was related to the proinsulin/insulin ratio (a marker of insulin secretion), but none of the PFAS was related to the HOMA-IR (a marker of insulin resistance) following adjustment for multiple confounders.

Conclusions/interpretation

PFNA was related to prevalent diabetes in a non-monotonic fashion in this cross-sectional study, supporting the view that this perfluoroalkyl substance might influence glucose metabolism in humans at the level of exposure seen in the general elderly population.
Literature
1.
go back to reference Paul AG, Jones KC, Sweetman AJ (2009) A first global production, emission, and environmental inventory for perfluorooctane sulfonate. Environ Sci Technol 43:386–392PubMedCrossRef Paul AG, Jones KC, Sweetman AJ (2009) A first global production, emission, and environmental inventory for perfluorooctane sulfonate. Environ Sci Technol 43:386–392PubMedCrossRef
2.
go back to reference Kennedy GL Jr, Butenhoff JL, Olsen GW et al (2004) The toxicology of perfluorooctanoate. Crit Rev Toxicol 34:351–384PubMedCrossRef Kennedy GL Jr, Butenhoff JL, Olsen GW et al (2004) The toxicology of perfluorooctanoate. Crit Rev Toxicol 34:351–384PubMedCrossRef
3.
go back to reference Conder JM, Hoke RA, de Wolf W, Russell MH, Buck RC (2008) Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds. Environ Sci Technol 42:995–1003PubMedCrossRef Conder JM, Hoke RA, de Wolf W, Russell MH, Buck RC (2008) Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds. Environ Sci Technol 42:995–1003PubMedCrossRef
4.
go back to reference Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J (2007) Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366–394PubMedCrossRef Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J (2007) Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366–394PubMedCrossRef
5.
go back to reference Svensson K, Hernandez-Ramirez RU, Burguete-Garcia A et al (2011) Phthalate exposure associated with self-reported diabetes among Mexican women. Environ Res 111:792–796PubMedCrossRef Svensson K, Hernandez-Ramirez RU, Burguete-Garcia A et al (2011) Phthalate exposure associated with self-reported diabetes among Mexican women. Environ Res 111:792–796PubMedCrossRef
6.
go back to reference Lind PM, Zethelius B, Lind L (2012) Circulating levels of phthalate metabolites are associated with prevalent diabetes in the elderly. Diabetes Care 35:1519–1524PubMedCrossRef Lind PM, Zethelius B, Lind L (2012) Circulating levels of phthalate metabolites are associated with prevalent diabetes in the elderly. Diabetes Care 35:1519–1524PubMedCrossRef
7.
go back to reference James-Todd T, Stahlhut R, Meeker JD et al (2012) Urinary phthalate metabolite concentrations and diabetes among women in the National Health and Nutrition Examination Survey (NHANES) 2001–2008. Environ Health Perspect 120:1307–1313PubMedCentralPubMedCrossRef James-Todd T, Stahlhut R, Meeker JD et al (2012) Urinary phthalate metabolite concentrations and diabetes among women in the National Health and Nutrition Examination Survey (NHANES) 2001–2008. Environ Health Perspect 120:1307–1313PubMedCentralPubMedCrossRef
8.
go back to reference Nelson JW, Hatch EE, Webster TF (2010) Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ Health Perspect 118:197–202PubMedCentralPubMedCrossRef Nelson JW, Hatch EE, Webster TF (2010) Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ Health Perspect 118:197–202PubMedCentralPubMedCrossRef
9.
go back to reference Lv Z, Li G, Li Y et al (2013) Glucose and lipid homeostasis in adult rat is impaired by early-life exposure to perfluorooctane sulfonate. Environmental toxicology 28:532–542PubMedCrossRef Lv Z, Li G, Li Y et al (2013) Glucose and lipid homeostasis in adult rat is impaired by early-life exposure to perfluorooctane sulfonate. Environmental toxicology 28:532–542PubMedCrossRef
10.
go back to reference Leonard RC, Kreckmann KH, Sakr CJ, Symons JM (2008) Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol 18:15–22PubMedCrossRef Leonard RC, Kreckmann KH, Sakr CJ, Symons JM (2008) Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol 18:15–22PubMedCrossRef
11.
go back to reference MacNeil J, Steenland NK, Shankar A, Ducatman A (2009) A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA). Environ Res 109:997–1003PubMedCrossRef MacNeil J, Steenland NK, Shankar A, Ducatman A (2009) A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA). Environ Res 109:997–1003PubMedCrossRef
12.
go back to reference Lin CY, Chen PC, Lin YC, Lin LY (2009) Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults. Diabetes care 32:702–707PubMedCrossRef Lin CY, Chen PC, Lin YC, Lin LY (2009) Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults. Diabetes care 32:702–707PubMedCrossRef
13.
go back to reference Vasiliu O, Cameron L, Gardiner J, Deguire P, Karmaus W (2006) Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus. Epidemiology 17:352–359PubMedCrossRef Vasiliu O, Cameron L, Gardiner J, Deguire P, Karmaus W (2006) Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus. Epidemiology 17:352–359PubMedCrossRef
14.
go back to reference Turyk M, Anderson H, Knobeloch L, Imm P, Persky V (2009) Organochlorine exposure and incidence of diabetes in a cohort of Great Lakes sport fish consumers. Environ Health Perspect 2117:1076–1082 Turyk M, Anderson H, Knobeloch L, Imm P, Persky V (2009) Organochlorine exposure and incidence of diabetes in a cohort of Great Lakes sport fish consumers. Environ Health Perspect 2117:1076–1082
15.
go back to reference Lee DH, Steffes MW, Sjödin A, Jones RS, Needham LL, Jacobs DR Jr (2010) Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case–control study. Environ Health Perspect 118:1235–1242PubMedCentralPubMedCrossRef Lee DH, Steffes MW, Sjödin A, Jones RS, Needham LL, Jacobs DR Jr (2010) Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case–control study. Environ Health Perspect 118:1235–1242PubMedCentralPubMedCrossRef
17.
go back to reference Lee DH, Lind PM, Jacobs DR Jr, Salihovic S, van Bavel B, Lind L (2011) Polychlorinated biphenyls and organochlorine pesticides in plasma predict development of type 2 diabetes in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Diabetes Care 34:1778–1784PubMedCrossRef Lee DH, Lind PM, Jacobs DR Jr, Salihovic S, van Bavel B, Lind L (2011) Polychlorinated biphenyls and organochlorine pesticides in plasma predict development of type 2 diabetes in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Diabetes Care 34:1778–1784PubMedCrossRef
18.
go back to reference Lang IA, Galloway TS, Scarlett A et al (2008) Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300:1303–1310PubMedCrossRef Lang IA, Galloway TS, Scarlett A et al (2008) Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300:1303–1310PubMedCrossRef
19.
go back to reference Lind L, Fors N, Hall J, Marttala K, Stenborg A (2005) A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Arterioscler, Thromb, Vasc Biol 25:2368–2375CrossRef Lind L, Fors N, Hall J, Marttala K, Stenborg A (2005) A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Arterioscler, Thromb, Vasc Biol 25:2368–2375CrossRef
20.
go back to reference Carlsson L, Lind L, Larsson A (2010) Reference values for 27 clinical chemistry tests in 70-year-old males and females. Gerontology 56:259–265PubMedCrossRef Carlsson L, Lind L, Larsson A (2010) Reference values for 27 clinical chemistry tests in 70-year-old males and females. Gerontology 56:259–265PubMedCrossRef
21.
go back to reference Davies MJ, Rayman G, Gray IP, Day JL, Hales CN (1993) Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 10:313–320PubMedCrossRef Davies MJ, Rayman G, Gray IP, Day JL, Hales CN (1993) Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 10:313–320PubMedCrossRef
22.
go back to reference Kahn SE, Halban PA (1997) Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 46:1725–1732PubMedCrossRef Kahn SE, Halban PA (1997) Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 46:1725–1732PubMedCrossRef
23.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef
24.
go back to reference Salihovic S, Karrman A, Lindstrom G, Lind PM, Lind L, van Bavel B (2013) A rapid method for the determination of perfluoroalkyl substances including structural isomers of perfluorooctane sulfonic acid in human serum using 96-well plates and column-switching ultra-high performance liquid chromatography tandem mass spectrometry. J Chromatogr, A 1305:164–170CrossRef Salihovic S, Karrman A, Lindstrom G, Lind PM, Lind L, van Bavel B (2013) A rapid method for the determination of perfluoroalkyl substances including structural isomers of perfluorooctane sulfonic acid in human serum using 96-well plates and column-switching ultra-high performance liquid chromatography tandem mass spectrometry. J Chromatogr, A 1305:164–170CrossRef
25.
go back to reference Lebovitz HE, Banerji MA (2001) Insulin resistance and its treatment by thiazolidinediones. Recent Prog Horm Res 56:265–294PubMedCrossRef Lebovitz HE, Banerji MA (2001) Insulin resistance and its treatment by thiazolidinediones. Recent Prog Horm Res 56:265–294PubMedCrossRef
26.
go back to reference Lupi R, Del Guerra S, Marselli L et al (2004) Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARγ2 in the modulation of insulin secretion. Am J Physiol Endocrinol Metab 286:E560–E567PubMedCrossRef Lupi R, Del Guerra S, Marselli L et al (2004) Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARγ2 in the modulation of insulin secretion. Am J Physiol Endocrinol Metab 286:E560–E567PubMedCrossRef
27.
go back to reference Thomas EL, Potter E, Tosi I et al (2007) Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: relation to liver, muscle and regional body fat content. Atherosclerosis 195:e181–e190PubMedCrossRef Thomas EL, Potter E, Tosi I et al (2007) Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: relation to liver, muscle and regional body fat content. Atherosclerosis 195:e181–e190PubMedCrossRef
28.
go back to reference Moon JH, Kim HJ, Kim SK et al (2011) Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment. Metabolism 60:165–172PubMedCrossRef Moon JH, Kim HJ, Kim SK et al (2011) Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment. Metabolism 60:165–172PubMedCrossRef
29.
go back to reference Vongphachan V, Cassone CG, Wu D, Chiu S, Crump D, Kennedy SW (2011) Effects of perfluoroalkyl compounds on mRNA expression levels of thyroid hormone-responsive genes in primary cultures of avian neuronal cells. Toxicol Sci 120:392–402PubMedCrossRef Vongphachan V, Cassone CG, Wu D, Chiu S, Crump D, Kennedy SW (2011) Effects of perfluoroalkyl compounds on mRNA expression levels of thyroid hormone-responsive genes in primary cultures of avian neuronal cells. Toxicol Sci 120:392–402PubMedCrossRef
30.
go back to reference Dallaire R, Dewailly E, Pereg D, Dery S, Ayotte P (2009) Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Environ Health Perspect 117:1380–1386PubMedCentralPubMedCrossRef Dallaire R, Dewailly E, Pereg D, Dery S, Ayotte P (2009) Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Environ Health Perspect 117:1380–1386PubMedCentralPubMedCrossRef
31.
go back to reference Power MC, Webster TF, Baccarelli AA, Weisskopf MG (2013) Cross-sectional association between polyfluoroalkyl chemicals and cognitive limitation in the National Health and Nutrition Examination Survey. Neuroepidemiology 40:125–132PubMedCentralPubMedCrossRef Power MC, Webster TF, Baccarelli AA, Weisskopf MG (2013) Cross-sectional association between polyfluoroalkyl chemicals and cognitive limitation in the National Health and Nutrition Examination Survey. Neuroepidemiology 40:125–132PubMedCentralPubMedCrossRef
Metadata
Title
Circulating levels of perfluoroalkyl substances and prevalent diabetes in the elderly
Authors
Lars Lind
Björn Zethelius
Samira Salihovic
Bert van Bavel
P. Monica Lind
Publication date
01-03-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 3/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-3126-3

Other articles of this Issue 3/2014

Diabetologia 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.